IP Library Granted Patent US 10,724,085
Granted Patent B2
US 10,724,085 · App. 15/902,819 · Granted Jul 28, 2020

Methods and compositions for nucleic acid amplification

Inventors: Steven T. Brentano (Santee, CA); Dmitry Lyakhov (San Diego, CA); Norman C. Nelson (San Diego, CA); James D. Carlson (San Diego, CA); Michael M. Becker (San Diego, CA); Lyle J. Arnold, Jr. (Poway, CA)
C12Q1/6865C12Q1/6844C12Q1/6848C12Q1/6853
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,085
App. No.
15/902,819
Granted
Jul 28, 2020
Kind
B2
Abstract

Compositions, reaction mixtures, and methods for performing an amplification reaction, including multiplex amplification reaction, wherein the method comprises using one or more amplification oligomer complexes comprising linked first and second amplification oligomer members. In one aspect, the amplification oligomer complex is hybridized to a target nucleic acid, the target nucleic acid with hybridized amplification oligomer complex is then captured, and other components are washed away. Target sequences of the target nucleic acids are pre-amplified to generate a first amplification product. The first amplification product is amplified in one or more secondary amplification reactions to generate second amplification products.

Claims (31)

1. A method for simultaneously amplifying at least two different target nucleic acid sequences contained in a sample comprising the steps of:

(a) contacting a sample with at least two different target capture oligomers and with at least two different amplification oligomer complexes;

(i) wherein each of said target capture oligomers and each of said amplification oligomer complexes hybridize to different target nucleic acid sequences,

(ii) wherein each of said amplification oligomer complexes comprises a non-promoter primer oligonucleotide having a first 3′ target specific sequence and a promoter oligonucleotide having a second 3′ target specific sequence and a 5′ promoter sequence, wherein the promoter oligonucleotide optionally comprises a blocked 3′ terminus, and wherein the non-promoter primer oligonucleotide is directly or indirectly joined to the promoter oligonucleotide;

(b) contacting said at least two target capture oligomers in step (a) with a solid support and immobilized probe for performing a target capture;

(c) washing said sample after target capture;

(d) pre-amplifying said target nucleic acid sequences using said amplification oligomer complexes, under conditions configured to maintain the amplification oligomer complexes, thereby generating first amplification products for each target nucleic acid hybridized by an amplification oligomer complex;

(e) splitting said pre-amplified sample into at least two separate secondary target specific amplification reactions;

(f) amplifying at least two of said pre-amplified samples generated in step (d) using target specific amplification oligomers that are not joined, thereby generating second amplification products.

2. The method of claim 1 , wherein the non-promoter primer oligonucleotide is joined to the promoter oligonucleotide via:

a direct hybridization (DH) complex between a first sequence in the non-promoter primer oligonucleotide and a second sequence in the promoter oligonucleotide that is complementary to the first sequence in the non-promoter primer oligonucleotide;

a hybridization complex comprising an S-oligonucleotide, wherein the S-oligonucleotide contains a first sequence complementary to a sequence in the promoter oligonucleotide and a second sequence complementary to a sequence in the non-promoter primer oligonucleotide; or

a non-nucleotide linker.

3. The method of claim 2 , wherein the non-promoter primer oligonucleotide is joined to the promoter oligonucleotide via the DH complex.

4. The method of claim 3 , wherein the first and second sequences of the DH complex are a 5′ sequence in the non-promoter primer oligonucleotide that is complementary to all or a portion of the promoter sequence in the promoter oligonucleotide.

5. The method of claim 1 , wherein the amplifying reaction at step (f) is a quantitative amplification reaction whereby an amplification product is detected during the amplification reaction.

6. The method of claim 1 , wherein the amplifying reaction at step (f) is an exponential amplification reaction.

7. The method of claim 1 , wherein the amplification reaction at step (f) is accomplished using a substantially isothermal amplification reaction.

8. The method of claim 1 , wherein a first amplification product generated in step (b) for a target nucleic acid hybridized by an amplification oligomer complex is from 100 to 10000 RNA transcripts.

9. The method of claim 1 , where the first amplification products generated at step (d) are divided into a number of secondary target specific amplification reactions that equals the number of different amplification oligomer complexes used in step (a).

10. The method of claim 1 , wherein the amplification oligomer complexes are formed before being added into the pre-amplifying reaction at step (d).

11. The method of claim 1 , wherein the amplification oligomer complexes are formed and then added into a target capture reaction mixture at step (a).

12. The method of claim 1 , wherein the amplification oligomer complexes are formed under hybridizing conditions during step (a).

13. The method of claim 1 , wherein the pre-amplifying reaction at step (d) further comprises using a blocker oligomer.

14. The method of claim 1 , further comprising detecting the second amplification products generated at step (f).

15. The method of claim 14 , wherein the second amplification products are detected using a probe-based detection step.

16. The method of claim 15 , wherein the probe-based detection step is a real-time detection step.

17. The method of claim 16 , wherein the second amplification products are detected using a detection probe oligomer selected from the group consisting of a molecular beacon, a molecular torch, and a hybridization switch probe.

18. The method of claim 14 , wherein the second amplification products are detected using a detection probe oligomer, mass spectrometry, nucleic acid sequencing, or gel electrophoresis.

19. The method of claim 1 , wherein each of the amplification oligomer complexes hybridizes to a different region on the same target nucleic acid.

20. The method of claim 1 , wherein each of the amplification oligomer complexes hybridizes to a different target nucleic acid.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2020
From: BRENTANO, STEVEN T.; LYAKHOV, DMITRY; ARNOLD, LYLE J., JR.; NELSON, NORMAN C.; BECKER, MICHAEL M.; CARLSON, JAMES D.
To: GEN-PROBE INCORPORATED
Reel/Frame 052963/0898 →
SECURITY INTEREST Recorded Oct 19, 2018
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED; CYNOSURE, INC.; FAXITRON BIOPTICS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047272/0347 →